tetano
Editor, Senior Moderator
NEJM Evid
. 2023 Sep;2(9):10.1056/evidoa2300046.
doi: 10.1056/evidoa2300046. Epub 2023 Jul 20. Long-Term Dysfunction of Taste Papillae in SARS-CoV-2
Qin Yao[SUP] 1 [/SUP], Máire E Doyle[SUP] 1 [/SUP], Qing-Rong Liu[SUP] 1 [/SUP], Ashley Appleton[SUP] 1 [/SUP], Jennifer F O'Connell[SUP] 1 [/SUP], Nan-Ping Weng[SUP] 2 [/SUP], Josephine M Egan[SUP] 1 [/SUP]
Affiliations
Background: We sought to determine whether ongoing taste disturbance in the postacute sequelae of coronavirus disease 2019 period is associated with persistent virus in primary taste tissue.
Methods: We performed fungiform papillae biopsies on 16 patients who reported taste disturbance lasting more than 6 weeks after molecularly determined severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Then, on multiple occasions, we rebiopsied 10 of those patients who still had taste complaints for at least 6 months postinfection. Fungiform papillae obtained from other patients before March 2020 served as negative controls. We performed hematoxylin and eosin staining to examine fungiform papillae morphology and immunofluorescence and fluorescence in situ hybridization to look for evidence of persistent viral infection and immune response.
Results: In all patients, we found evidence of SARS-CoV-2, accompanying immune response and misshapen or absent taste buds with loss of intergemmal neurite fibers. Six patients reported normal taste perception by 6 months postinfection and were not further biopsied. In the remaining 10, the virus was eliminated in a seemingly random fashion from their fungiform papillae, but four patients still, by history, reported incomplete return to preinfection taste perception by the time we wrote this report.
Conclusions: Our data show a temporal association in patients between functional taste, taste papillae morphology, and the presence of SARS-CoV-2 and its associated immunological changes. (Funded by Intramural Research Program/National Institute on Aging/National Institute of Allergy and Infectious Diseases/National Institutes of Health; ClinicalTrials.gov numbers NCT03366168 and NCT04565067.).
. 2023 Sep;2(9):10.1056/evidoa2300046.
doi: 10.1056/evidoa2300046. Epub 2023 Jul 20. Long-Term Dysfunction of Taste Papillae in SARS-CoV-2
Qin Yao[SUP] 1 [/SUP], Máire E Doyle[SUP] 1 [/SUP], Qing-Rong Liu[SUP] 1 [/SUP], Ashley Appleton[SUP] 1 [/SUP], Jennifer F O'Connell[SUP] 1 [/SUP], Nan-Ping Weng[SUP] 2 [/SUP], Josephine M Egan[SUP] 1 [/SUP]
Affiliations
- PMID: 38145006
- PMCID: PMC10745124
- DOI: 10.1056/evidoa2300046
Background: We sought to determine whether ongoing taste disturbance in the postacute sequelae of coronavirus disease 2019 period is associated with persistent virus in primary taste tissue.
Methods: We performed fungiform papillae biopsies on 16 patients who reported taste disturbance lasting more than 6 weeks after molecularly determined severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Then, on multiple occasions, we rebiopsied 10 of those patients who still had taste complaints for at least 6 months postinfection. Fungiform papillae obtained from other patients before March 2020 served as negative controls. We performed hematoxylin and eosin staining to examine fungiform papillae morphology and immunofluorescence and fluorescence in situ hybridization to look for evidence of persistent viral infection and immune response.
Results: In all patients, we found evidence of SARS-CoV-2, accompanying immune response and misshapen or absent taste buds with loss of intergemmal neurite fibers. Six patients reported normal taste perception by 6 months postinfection and were not further biopsied. In the remaining 10, the virus was eliminated in a seemingly random fashion from their fungiform papillae, but four patients still, by history, reported incomplete return to preinfection taste perception by the time we wrote this report.
Conclusions: Our data show a temporal association in patients between functional taste, taste papillae morphology, and the presence of SARS-CoV-2 and its associated immunological changes. (Funded by Intramural Research Program/National Institute on Aging/National Institute of Allergy and Infectious Diseases/National Institutes of Health; ClinicalTrials.gov numbers NCT03366168 and NCT04565067.).